ici 204,219 has been researched along with albuterol in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (24.00) | 18.2507 |
| 2000's | 13 (52.00) | 29.6817 |
| 2010's | 6 (24.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Aleo, MD; Bonin, PD; Luo, Y; Potter, DM; Swiss, R; Will, Y | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Barnes, NC; Hui, KP | 1 |
| Dykewicz, MS; Ledford, DK | 1 |
| Bonuccelli, CM; Howland, WC; Minkwitz, MC; Nathan, RA; Simonson, SG; Tashkin, DP | 1 |
| Deykin, A; Israel, E | 1 |
| Busse, W; Kalberg, C; Nelson, H; Rickard, KA; Wolfe, J; Yancey, SW | 1 |
| Burstein-Stein, J; Grieco, AJ | 1 |
| Allegra, L; Boveri, B; Carlucci, P; Cazzola, M; Centanni, S; DiMarco, F; Santus, P | 1 |
| Dunn, CJ; Goa, KL | 1 |
| Dorinsky, PM; Edwards, LD; Rickard, KA; Yancey, SW | 1 |
| Kalberg, C; Nathan, RA; Nelson, HS; Rickard, KA; Yancey, SW | 1 |
| Cates, C | 1 |
| Allegra, L; Boveri, B; Cazzola, M; Centanni, S; Di Marco, F; Matera, MG; Santus, P | 1 |
| Flores, DM; Nannini, LJ | 1 |
| Barreta, RA; Lau, BH; Lau, EW; Riesen, SK; Rohdewald, P; Truong, KP | 1 |
| Hiyama, Y; Ishimura, M; Kataoka, S; Maeda, T; Suda, M | 1 |
6 review(s) available for ici 204,219 and albuterol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Recent findings in asthma likely to impact patient care.
Topics: Adrenergic beta-Agonists; Albuterol; Anti-Asthmatic Agents; Asthma; Gastroesophageal Reflux; Humans; Indoles; Inflammation; Leukotriene Antagonists; Phenylcarbamates; Salmeterol Xinafoate; Sulfonamides; Tosyl Compounds | 1998 |
Newer therapeutic agents for asthma.
Topics: Adrenergic beta-Agonists; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Cyclosporine; Fluticasone; Forced Expiratory Volume; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Indoles; Leukotriene Antagonists; Lidocaine; Methotrexate; Phenylcarbamates; Salmeterol Xinafoate; Sulfonamides; Tosyl Compounds; Treatment Outcome | 1999 |
Zafirlukast: an update of its pharmacology and therapeutic efficacy in asthma.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Albuterol; Anti-Asthmatic Agents; Asthma; Child; Child, Preschool; Chromones; Humans; Indoles; Leukotriene Antagonists; Middle Aged; Phenylcarbamates; Salmeterol Xinafoate; Sulfonamides; Tosyl Compounds | 2001 |
Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids.
Topics: Administration, Inhalation; Administration, Oral; Adrenergic beta-Agonists; Adult; Albuterol; Anti-Asthmatic Agents; Asthma; Female; Glucocorticoids; Humans; Indoles; Leukotriene Antagonists; Male; Phenylcarbamates; Randomized Controlled Trials as Topic; Salmeterol Xinafoate; Sulfonamides; Tosyl Compounds | 2001 |
Chronic asthma.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Asthma; Beclomethasone; Chronic Disease; Drug Therapy, Combination; Glucocorticoids; Humans; Indoles; Leukotriene Antagonists; Phenylcarbamates; Randomized Controlled Trials as Topic; Sulfonamides; Tosyl Compounds | 2001 |
8 trial(s) available for ici 204,219 and albuterol
| Article | Year |
|---|---|
Lung function improvement in asthma with a cysteinyl-leukotriene receptor antagonist.
Topics: Administration, Inhalation; Adult; Airway Resistance; Albuterol; Asthma; Bronchoconstriction; Double-Blind Method; Drug Evaluation; Female; Forced Expiratory Volume; Humans; Indoles; Leukotriene Antagonists; Male; Middle Aged; Phenylcarbamates; Sulfonamides; Tosyl Compounds | 1991 |
An evaluation of zafirlukast in the treatment of asthma with exploratory subset analyses.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Albuterol; Analysis of Variance; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Child; Circadian Rhythm; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Indoles; Male; Phenylcarbamates; Sulfonamides; Tosyl Compounds | 1999 |
Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma.
Topics: Administration, Inhalation; Administration, Oral; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Asthma; Bronchodilator Agents; Circadian Rhythm; Double-Blind Method; Female; Humans; Indoles; Leukotriene Antagonists; Lung; Male; Middle Aged; Phenylcarbamates; Respiratory Function Tests; Salmeterol Xinafoate; Severity of Illness Index; Sulfonamides; Therapeutic Equivalency; Tosyl Compounds | 1999 |
Lung function improvement in smokers suffering from COPD with zafirlukast, a CysLT(1)-receptor antagonist.
Topics: Aged; Albuterol; Anti-Asthmatic Agents; Area Under Curve; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Female; Humans; Indoles; Lung; Lung Diseases, Obstructive; Male; Middle Aged; Phenylcarbamates; Respiratory Function Tests; Smoking; Spirometry; Sulfonamides; Tosyl Compounds; Treatment Outcome | 2000 |
Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids.
Topics: Administration, Inhalation; Administration, Oral; Adrenergic beta-Agonists; Adult; Albuterol; Anti-Asthmatic Agents; Asthma; Female; Glucocorticoids; Humans; Indoles; Leukotriene Antagonists; Male; Phenylcarbamates; Randomized Controlled Trials as Topic; Salmeterol Xinafoate; Sulfonamides; Tosyl Compounds | 2001 |
Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.
Topics: Adrenergic beta-Agonists; Adult; Aged; Albuterol; Asthma; Bronchi; Bronchodilator Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Indoles; Leukotriene Antagonists; Male; Middle Aged; Phenylcarbamates; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Sulfonamides; Tosyl Compounds | 2001 |
Bronchodilator effect of zafirlukast in subjects with chronic obstructive pulmonary disease.
Topics: Administration, Oral; Aged; Albuterol; Bronchodilator Agents; Female; Humans; Indoles; Lung; Male; Middle Aged; Phenylcarbamates; Pulmonary Disease, Chronic Obstructive; Sulfonamides; Tosyl Compounds | 2003 |
Pycnogenol as an adjunct in the management of childhood asthma.
Topics: Adolescent; Albuterol; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Antioxidants; Asthma; Bronchodilator Agents; Child; Double-Blind Method; Drug Therapy, Combination; Female; Flavonoids; Humans; Indoles; Male; Phenylcarbamates; Plant Extracts; Respiratory Function Tests; Sulfonamides; Tosyl Compounds | 2004 |
12 other study(ies) available for ici 204,219 and albuterol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Humans; Male; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Severity of Illness Index | 2014 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Drugs for asthma.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adolescent; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Asthma; Bone Density; Bronchial Spasm; Bronchodilator Agents; Child; Child, Preschool; Choice Behavior; Cromolyn Sodium; Cyclopropanes; Exercise; Female; Growth; Humans; Hydroxyurea; Indoles; Infant, Newborn; Ipratropium; Lactation; Leukotriene Antagonists; Phenylcarbamates; Pregnancy; Pregnancy Complications; Quinolines; Salmeterol Xinafoate; Sulfides; Sulfonamides; Tachycardia; Theophylline; Tosyl Compounds | 1999 |
Drugs for asthma.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Bronchial Spasm; Child; Cromolyn Sodium; Cyclopropanes; Exercise; Female; Growth Disorders; Humans; Hydroxyurea; Indoles; Ipratropium; Lactation; Leukotriene Antagonists; Nebulizers and Vaporizers; Nedocromil; Phenylcarbamates; Pregnancy; Pregnancy Complications; Quinolines; Salmeterol Xinafoate; Sulfides; Sulfonamides; Theophylline; Tosyl Compounds | 2000 |
The use of newer asthma and allergy medications during pregnancy. The American College of Obstetricians and Gynecologists (ACOG) and The American College of Allergy, Asthma and Immunology (ACAAI).
Topics: Abnormalities, Drug-Induced; Acetates; Administration, Inhalation; Administration, Intranasal; Administration, Oral; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Albuterol; Animals; Anti-Allergic Agents; Anti-Asthmatic Agents; Asthma; Budesonide; Chlorpheniramine; Cyclopropanes; Ephedrine; Female; Histamine H1 Antagonists; Humans; Hydroxyurea; Hypersensitivity; Indoles; Ipratropium; Leukotriene Antagonists; Metaproterenol; Nasal Decongestants; Nebulizers and Vaporizers; Nedocromil; Phenylcarbamates; Pregnancy; Pregnancy Complications; Quinolines; Salmeterol Xinafoate; Sulfides; Sulfonamides; Terbutaline; Tosyl Compounds; Tripelennamine | 2000 |
Oral montelukast versus inhaled salmeterol to prevent exercise-induced bronchoconstriction.
Topics: Acetates; Aged; Albuterol; Anti-Asthmatic Agents; Asthma, Exercise-Induced; Bronchodilator Agents; Chemical and Drug Induced Liver Injury; Cyclopropanes; Female; Humans; Indoles; Leukotriene Antagonists; Phenylcarbamates; Quinolines; Salmeterol Xinafoate; Sulfides; Sulfonamides; Tosyl Compounds | 2000 |
Use of changes in symptoms to predict changes in lung function in assessing the response to asthma therapy.
Topics: Adolescent; Adult; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Double-Blind Method; Dyssomnias; Female; Fluticasone; Humans; Indoles; Male; Phenylcarbamates; Quality of Life; Regression Analysis; Respiratory Function Tests; Retrospective Studies; Salmeterol Xinafoate; Sulfonamides; Tosyl Compounds | 2001 |
Effects of KP-496, a novel dual antagonist for leukotriene D4 and thromboxane A2 receptors, on contractions induced by various agonists in the guinea pig trachea.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetates; Acetylcholine; Albuterol; Animals; Atropine; Benzoquinones; Carbachol; Chromones; Cyclopropanes; Dinoprost; Drug Evaluation, Preclinical; Guinea Pigs; Heptanoic Acids; Histamine; In Vitro Techniques; Indoles; Indomethacin; Ketanserin; Ketotifen; Leukotriene Antagonists; Leukotriene D4; Male; Muscle Contraction; Muscle, Smooth; Phenylcarbamates; Powders; Procaterol; Prostaglandin Antagonists; Prostaglandin D2; Quinolines; Receptors, Thromboxane A2, Prostaglandin H2; Serotonin; Substance P; Sulfides; Sulfonamides; Tosyl Compounds; Trachea; Tryptophan | 2006 |